Polyclonal Antibodies Market

Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
Polyclonal Antibodies Market contains market size and forecasts of Polyclonal Antibodies in global, including the following market information:
Global Polyclonal Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Polyclonal Antibodies Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Polyclonal Antibodies companies in 2021 (%)
The global Polyclonal Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Primary Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Polyclonal Antibodies include Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech, Gallus Immunotech, Creative Diagnostics, Agrisera and Innovagen AB, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Polyclonal Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Polyclonal Antibodies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Polyclonal Antibodies Market Segment Percentages, by Type, 2021 (%)
Primary Antibody
Secondary Antibody
Global Polyclonal Antibodies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Polyclonal Antibodies Market Segment Percentages, by Application, 2021 (%)
Academic Research
Commercial
Global Polyclonal Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Polyclonal Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Polyclonal Antibodies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Polyclonal Antibodies revenues share in global market, 2021 (%)
Key companies Polyclonal Antibodies sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Polyclonal Antibodies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex